MedTrace Logo

Mortality After Endoscopic Retrograde Cholangiopancreatography

NCT02983331 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1471

Last updated 2016-12-06

No results posted yet for this study

Summary

In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility

Conditions

  • Cholangiopancreatography, Endoscopic Retrograde
  • Mortality
  • Deep Sedation

Interventions

PROCEDURE

complications during procedure

patients may have anesthesia related complications during procedure

Sponsors & Collaborators

  • Gulsah Karaoren

    lead OTHER_GOV

Principal Investigators

  • Gulsah Karaoren, MD · Umraniye Research Hospital

Eligibility

Min Age
42 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02983331 on ClinicalTrials.gov